Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 226

1.

Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients.

Deugnier YM, Charalambous P, Le Quilleuc D, Turlin B, Searle J, Brissot P, Powell LW, Halliday JW.

Hepatology. 1993 Dec;18(6):1363-9.

PMID:
7902316
[PubMed - indexed for MEDLINE]
3.

Detection of the preneoplastic lesions of small hepatocellular carcinoma in cirrhotic livers.

Seki S, Sakaguchi H, Kawakita N, Yanai A, Tamori A, Yabusako T, Nishiguchi S, Kuroki T, Kobayashi K, Monna T.

J Gastroenterol Hepatol. 1993 Nov-Dec;8(6):582-9.

PMID:
7904190
[PubMed - indexed for MEDLINE]
4.

Resistance to iron accumulation and presence of hepatitis B surface antigen in preneoplastic and neoplastic lesions in human hemochromatotic livers.

Hirota N, Hamazaki M, Williams GM.

Hepatogastroenterology. 1982 Apr;29(2):49-51.

PMID:
6282722
[PubMed - indexed for MEDLINE]
5.

Kupffer cell iron overload induces intercellular adhesion molecule-1 expression on hepatocytes in genetic hemochromatosis.

Stål P, Broomé U, Scheynius A, Befrits R, Hultcrantz R.

Hepatology. 1995 May;21(5):1308-16.

PMID:
7737636
[PubMed - indexed for MEDLINE]
6.

The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.

Yeh MM, Larson AM, Campbell JS, Fausto N, Rulyak SJ, Swanson PE.

Am J Surg Pathol. 2007 May;31(5):681-9.

PMID:
17460450
[PubMed - indexed for MEDLINE]
7.

Magnetic resonance iron-free nodules in genetic hemochromatosis.

Guyader D, Gandon Y, Sapey T, Turlin B, Mendler MH, Brissot P, Deugnier Y.

Am J Gastroenterol. 1999 Apr;94(4):1083-6.

PMID:
10201487
[PubMed - indexed for MEDLINE]
8.

Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia.

Su Q, Benner A, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P.

Virchows Arch. 1997 Dec;431(6):391-406.

PMID:
9428927
[PubMed - indexed for MEDLINE]
9.

Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma. Evidence against precancerous nature of liver cell dysplasia.

Henmi A, Uchida T, Shikata T.

Cancer. 1985 Jun 1;55(11):2594-9.

PMID:
2986818
[PubMed - indexed for MEDLINE]
10.

Liver transplantation to treat suspected hepatocellular carcinoma in iron-free foci in congenital hemochromatosis: case report.

Quante M, Benckert C, Thelen A, Uhlmann D, Bartels M, Moche M, Dollinger M, Wittekind C, Jonas S.

Transplant Proc. 2011 Jun;43(5):2066-9. doi: 10.1016/j.transproceed.2011.02.061.

PMID:
21693327
[PubMed - indexed for MEDLINE]
11.

Survey of iron-accumulative macroregenerative nodules in cirrhotic livers.

Terada T, Nakanuma Y.

Hepatology. 1989 Nov;10(5):851-4.

PMID:
2807165
[PubMed - indexed for MEDLINE]
12.

Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis?

Fracanzani AL, Borzio M, Roncalli M, Derenzini M, Trerè D, Mattioli M, Taioli E, Fiorelli G, Fargion S.

Am J Gastroenterol. 2000 Oct;95(10):2940-5.

PMID:
11051372
[PubMed - indexed for MEDLINE]
13.

Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic liver. A marker of incipient neoplastic lesions.

Terada T, Nakanuma Y.

Arch Pathol Lab Med. 1989 Aug;113(8):916-20.

PMID:
2757493
[PubMed - indexed for MEDLINE]
14.

[Premalignant lesions and hepatocellular carcinoma on non cirrhotic liver overloaded with iron].

Attia A, Blanc JF, Saric J, Balabaud C, Bioulac-Sage P.

Gastroenterol Clin Biol. 2000 Oct;24(10):955-9. French.

PMID:
11084432
[PubMed - indexed for MEDLINE]
Free Article
15.

Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases.

Deugnier YM, Guyader D, Crantock L, Lopez JM, Turlin B, Yaouanq J, Jouanolle H, Campion JP, Launois B, Halliday JW, et al.

Gastroenterology. 1993 Jan;104(1):228-34.

PMID:
8419246
[PubMed - indexed for MEDLINE]
16.

Hepatocyte senescence in end-stage chronic liver disease: a study of cyclin-dependent kinase inhibitor p21 in liver biopsies as a marker for progression to hepatocellular carcinoma.

Brunt EM, Walsh SN, Hayashi PH, Labundy J, Di Bisceglie AM.

Liver Int. 2007 Jun;27(5):662-71.

PMID:
17498252
[PubMed - indexed for MEDLINE]
17.

Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation.

Blanc JF, De Ledinghen V, Trimoulet P, Le Bail B, Bernard PH, Saric J, Balabaud C, Bioulac-Sage P.

J Hepatol. 1999 Feb;30(2):325-9.

PMID:
10068114
[PubMed - indexed for MEDLINE]
18.

HLA-linked hemochromatosis and other forms of iron overload.

Bloom PD, Gordeuk VR, MacPhail AP.

Dermatol Clin. 1995 Jan;13(1):57-63. Review.

PMID:
7712651
[PubMed - indexed for MEDLINE]
19.

Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver.

Turlin B, Juguet F, Moirand R, Le Quilleuc D, Loréal O, Campion JP, Launois B, Ramée MP, Brissot P, Deugnier Y.

Hepatology. 1995 Aug;22(2):446-50.

PMID:
7635411
[PubMed - indexed for MEDLINE]
20.

Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.

Farinati F, Cardin R, D'Errico A, De Maria N, Naccarato R, Cecchetto A, Grigioni W.

Hepatology. 1996 Jun;23(6):1468-75.

PMID:
8675166
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk